These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35190067)

  • 1. Lasers, lights, and compounds for hair loss in aesthetics.
    Ring CM; Finney R; Avram M
    Clin Dermatol; 2022; 40(1):64-75. PubMed ID: 35190067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of androgenic alopecia: a systematic review of the literature.
    Rosenthal A; Conde G; Greco JF; Gharavi NM
    J Cosmet Laser Ther; 2024; 26(1-4):1-16. PubMed ID: 38852607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
    Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy in female pattern hair loss.
    Deoghare S; Sadick NS
    J Cosmet Laser Ther; 2023 May; 25(1-4):1-6. PubMed ID: 37289953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
    Suchonwanit P; Iamsumang W; Rojhirunsakool S
    Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the treatment of male pattern hair loss.
    York K; Meah N; Bhoyrul B; Sinclair R
    Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
    [No Abstract]   [Full Text] [Related]  

  • 7. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
    Adil A; Godwin M
    J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study.
    Pindado-Ortega C; Saceda-Corralo D; Buendía-Castaño D; Fernández-González P; Moreno-Arrones ÓM; Fonda-Pascual P; Alegre-Sánchez A; Rodrigues-Barata AR; Vañó-Galván S
    Actas Dermosifiliogr (Engl Ed); 2018; 109(6):536-542. PubMed ID: 29656764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical and procedural treatment of androgenetic alopecia - Where are we?
    Ly NY; Fruechte S; Hordinsky MK; Sadick N; Arruda S; Farah RS
    J Am Acad Dermatol; 2023 Aug; 89(2S):S36-S39. PubMed ID: 37591565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical Treatment for Androgenetic Alopecia.
    Panchaprateep R
    Facial Plast Surg; 2024 Apr; 40(2):252-266. PubMed ID: 37871637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Hair Rejuvenation.
    Sand J; Walen S
    Clin Plast Surg; 2023 Jul; 50(3):509-520. PubMed ID: 37169416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
    Manabe M; Tsuboi R; Itami S; Osada SI; Amoh Y; Ito T; Inui S; Ueki R; Ohyama M; Kurata S; Kono T; Saito N; Sato A; Shimomura Y; Nakamura M; Narusawa H; Yamazaki M;
    J Dermatol; 2018 Sep; 45(9):1031-1043. PubMed ID: 29863806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgenetic alopecia: an evidence-based treatment update.
    Varothai S; Bergfeld WF
    Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive Hair Rejuvenation.
    Sand J; Walen S
    Facial Plast Surg Clin North Am; 2022 Aug; 30(3):419-431. PubMed ID: 35934443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil
    Gentile P; Garcovich S
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled dose-effect studies with topical minoxidil 2% or 5% in male-patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol.
    Van Neste D
    Skin Res Technol; 2020 Jul; 26(4):542-557. PubMed ID: 31957152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of laser and energy-assisted drug delivery in the treatment of alopecia.
    Balazic E; Muskat A; Kost Y; Cohen JL; Kobets K
    Lasers Med Sci; 2024 Feb; 39(1):73. PubMed ID: 38381230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
    Suchonwanit P; Rojhirunsakool S; Khunkhet S
    Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution.
    Marotta JC; Patel G; Carvalho M; Blakeney S
    Int J Pharm Compd; 2020; 24(1):69-76. PubMed ID: 32023218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.